The Recall Desk
HighFDA (Devices)·Z-2683-2024·Announced 2024-08-28

FDA Recalls BioFire Pneumonia Diagnostic Test Kits for Control Failures

BioFire Diagnostics recalls BIOFIRE FILMARRAY Pneumonia Panel plus test kits due to manufacturing defects that could lead to control failures and delayed test results. The affected kits were distributed in multiple US states and countries worldwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is a Class II diagnostic device with a manufacturing defect creating risk of control failures and delayed results. The source describes a risk-of-harm scenario with no reported illnesses or injuries, which per the rubric qualifies as High severity.

Plain-English summary

BioFire Diagnostics, LLC is recalling BIOFIRE FILMARRAY Pneumonia Panel plus test kits (REF: RFIT-ASY-0143) due to a manufacturing process defect that increases the risk of control failures. These failures could result in delayed test results, potentially delaying diagnosis in patients undergoing pneumonia testing.

The affected units include lot number 2147723 (expiration 27-Aug-2024) and were distributed worldwide including the United States (West Virginia, Indiana, and Alabama), France, Italy, Spain, Greece, Japan, Singapore, Chile, Taiwan, Israel, Romania, Ecuador, and Serbia. The U.S. Food and Drug Administration classified this recall as Class II.

Healthcare facilities that received affected kits should stop using them and contact BioFire Diagnostics, LLC for replacement or further instructions on how to proceed.

The recalled product

Product
BIOFIRE FILMARRAY Pneumonia Panel plus, REF: RFIT-ASY-0143
Manufacturer
BioFire Diagnostics, LLC
Hazard
  • control-failure
  • delayed-results

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UDI-DI: 00815381020314. Lot/Expiration: 2147723/27-Aug-2024

Distribution

Distributed nationwide across the United States.